Point-of-Care Diagnostics: What Changes When Results Arrive in 8 Minutes

Turnaround time is the quiet variable behind most diagnostic pathways. When a panel takes three days, the clinician plans around uncertainty. When the same panel resolves in eight minutes at the bedside, the decision moves from empirical to evidence-led.\n\nAcross three health-system deployments we instrumented in 2025, median time-to-treatment fell by 41% once assay results landed inside the encounter rather than after it. The interesting part was not the speed — it was the reduction in downstream escalation: fewer broad-spectrum starts, fewer repeat visits, fewer avoidable admissions.\n\nGetting there is an engineering problem as much as a clinical one. Cartridge chemistry has to tolerate real-world storage. The reader has to be operable by staff who did not train on it. And the result has to arrive inside the record the clinician is already looking at, not in a separate portal.\n\nThat last requirement is where most point-of-care programs stall. A validated assay that lives outside the workflow gets used once and abandoned.